Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04281004 · ClinicalTrials.gov registry record · Phase 1
Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)
A Phase 1 study of Photorefractive Keratectomy, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 61
- Enrollment target
- 1
- Study location
NCT04281004 is a Phase 1 study of Photorefractive Keratectomy that has completed, run by University of Utah. The registered enrollment target is 61 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04281004, a Phase 1 study of Photorefractive Keratectomy, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 61 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized, double-masked, placebo-controlled study to determine the safety of pAF in patients who undergo PRK.
Conditions Studied
Interventions
- BIOLOGICAL Amniotic Fluid (AFED)
- OTHER Saline Solution
Study Locations (1)
Utah
- Moran Eye Center, University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2020-07-10 |
| Est. Completion | 2023-01-16 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04281004
The ClinicalTrials.gov registry entry for NCT04281004 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Photorefractive Keratectomy appearing as the primary indexed condition, and to 2 interventions - of which Amniotic Fluid (AFED) is the first listed.
NCT04281004 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT04281004 about?
NCT04281004 is a clinical study titled "Processed Amniotic Fluid (PAF) Drops After Photorefractive Keratectomy (PRK)". This is a randomized, double-masked, placebo-controlled study to determine the safety of pAF in patients who undergo PRK.
What is the current status of trial NCT04281004?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 61 participants. The study started on 2020-07-10. Estimated completion is 2023-01-16.
What conditions does trial NCT04281004 study?
This clinical trial studies the following conditions: Photorefractive Keratectomy.
What interventions are being tested in trial NCT04281004?
The interventions under investigation include: Amniotic Fluid (AFED) (BIOLOGICAL), Saline Solution (OTHER).
Who is sponsoring clinical trial NCT04281004?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04281004 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Photorefractive Keratectomy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.